Greg Solis

Greg Solis is a seasoned professional in corporate strategy and business development within the pharmaceutical industry, currently serving as Senior Manager of Corporate Strategy at Crinetics Pharmaceuticals. Prior roles at Crinetics include Manager of Strategy & Business Development and Associate Manager of Business Development. Earlier experience includes leadership as Program Lead at DTxPharma and a Senior Analyst position at NuFund Venture Group, a prominent early-stage investor group in the US. Greg has also worked as a Business Development Consultant for the California Institute for Biomedical Research. Educational credentials comprise an MBA from the University of California, San Diego, a Ph.D. in Biochemistry from Scripps Research, and a B.S. in Biochemistry with a minor in Business Management from San Diego State University, complemented by relevant workshops and conventions.